American Vanguard (AVD) Gabelli Funds' 16th Annual Specialty Chemicals Symposium summary

Company overview and leadership

• Develops and markets crop protection, nutrition, turf, and pest control products globally.

• New CEO Dak Rice joined in December, bringing extensive agriculture industry experience.

• Operates six manufacturing facilities across North America, with a strong domestic footprint.

Business performance and transformation

• Core business has remained stable over the past 4-5 years despite industry volatility.

• Biological (green solutions) portfolio represents 10% of sales, with double-digit growth expected over the next 3-4 years.

• Transformation plan launched in 2024 targets a 15% EBITDA margin and double-digit EBITDA growth.

• 2024 EBITDA was $42 million on $563 million sales, with a 7.5% margin, impacted by industry oversupply.

• Significant Q4 actions included $22 million debt reduction, $47 million inventory reduction, and a $118 million write-off (Goodwill, SIMPAS, slow-moving inventory).

Strategic priorities and operational focus

• 2025 goals: strengthen balance sheet, simplify operations, focus on high-priority business, and expand EBITDA margin.

• Emphasis on manufacturing efficiency, optimizing R&D spend, and streamlining processes.

• Plans to leverage underutilized synthesis capacity and improve plant utilization for economies of scale.